For citations:
Valiev T.T., Shervashidze M.A., Osipova I.V., Burlutskaya T.I., Aleskerova G.A., Yuldasheva S.N., Sabantsev S.L., Paina O.V., Batmanova N.A., Zubarovskaya L.S., Kirgizov K.I., Varfolomeeva S.R. The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol. Oncohematology. 2024;19(4):23-31. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-4-23-31
Email this article 